←
Ryan Nipp, MD, MPH, MBA, FASCO5,011 posts
Ryan Nipp, MD, MPH, MBA, FASCO avatar✓

Ryan Nipp, MD, MPH, MBA, FASCO ✓

@RyanNipp

Oncologist and cancer outcomes researcher at the @UofOklahoma @OUCollegeofMed @StephensonCC || Passionate about improving cancer care || #PallOnc #GeriOnc

◷ Joined December 2012▧ 1,286 Photos and videos
Sumanta K. Pal, MD, FASCO avatar
⟳ Ryan Nipp, MD, MPH, MBA, FASCO retweeted
Sumanta K. Pal, MD, FASCO@montypal·Nov 4

Missed #ASCOQLTY26? Have a listen to the @ASCO Daily News Podcast for a conversation with @RyanNipp, this year's meetings chair. We highlight data from #DrGabrielleRocque related to the impact of CMS's Principal Illness Navigation codes, and @ShankaranVeena CREDIT trial, assessing the impact of proactive financial navigation. We move from there to the randomized #NutriCare study and then to @PauloBergerot's randomized assessment of exercise in patients getting checkpoint inhibitors. A brilliant array of abstracts, summarized in less than 25 minutes for your commute into the office!

Post attachment
Mina S. Sedrak avatar
⟳ Ryan Nipp, MD, MPH, MBA, FASCO retweeted
Mina S. Sedrak@minasedrakmd·Oct 28

Voting for the ASCO Election is now open. I am honored to be running as one of the candidates for the ASCO Nominating Committee. Visit asco.org/election to learn more about the candidates and place your vote!

Post attachment
Mina S. Sedrak avatar
⟳ Ryan Nipp, MD, MPH, MBA, FASCO retweeted
Mina S. Sedrak@minasedrakmd·Oct 20

Precision oncology has focused on the tumor. Is it time to put the patient at the center of patient-centered care? With @GRocqueMD and @RyanNipp, we put together this figure in @JCOOP_ASCO to share our thoughts on where we are today, when we think about precision oncology, and where we want to be in the future. Look at where the patient is in each panel. A: Tumor is at the center. Patient is off to the side. B: Patient moves to the middle. We add PROs. C: Patient is at the center. Everything else is around the patient: rumor biology is one part of the picture, along with aging or host biology, PROs that capture emotional and social health, environmental exposures, and the patient’s own goals and preferences... and perhaps AI can help us bring it all together... so we can personalize each person's risks and benefits. This is whole-person precision oncology. This is where we need to go. But.. one thing stays the same in every panel... the team. Medical, radiation, and surgical oncology. Geriatric oncology and palliative care. Nursing, pharmacy, and primary care. Academic and community practices. No one can see the whole person alone. We have to do this together. We have to do this as multidisplinary team. @ASCOPres #GeriOnc doi.org/10.1200/OP-26-00798

Post attachment
ASCO avatar
⟳ Ryan Nipp, MD, MPH, MBA, FASCO retweeted
ASCO@ASCO·Oct 17

The last session has ended, and our time at #ASCOQLTY26 has come to a close. Thank you to our incredible attendees, speakers, and patient advocates for coming together to share actionable insights, elevate care delivery, and improve outcomes for the cancer community. 🧡

0:30